Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination

Several cases of unusual thrombotic events and thrombocytopenia have developed after vaccination with the recombinant adenoviral vector encoding the spike protein antigen of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (ChAdOx1 nCov-19, AstraZeneca). More data were needed on the pathogenesis of this unusual clotting disorder.

Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination
Size: 601 KB